Meeting
2020 Gastrointestinal Cancers Symposium
Clinical outcomes of hepatocellular carcinoma patients with Child-Pugh class B treated with stereotactic body radiation therapy.
Authors
J Richelcyn Baclay
Stanford University, Stanford, CA
J Richelcyn Baclay , Diego Augusto Santos Toesca , Rie von Eyben , Madeline Minneci , Erqi L. Pollom , Daniel Tandel Chang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 560)
Abstract #
560
Poster Bd #
D21
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Liver toxicity following reirradiation and multiple-target SBRT for primary hepatocellular carcinoma.
First Author: Jacob Hall
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.
First Author: Timothy J Brown
Poster
2019 Gastrointestinal Cancers Symposium
Early stage hepatocellular carcinoma treated with stereotactic body radiation therapy: A pooled analysis from two North American institutions.
First Author: Ashwathy Susan Mathew
Poster
2018 Gastrointestinal Cancers Symposium
Stereotactic-body radiotherapy for portal vein tumor thrombosis in hepatocellular carcinoma patients.
First Author: Bae Kwon Jeong